
Sagimet Biosciences
A biopharmaceutical company developing therapeutics for the treatment of infectious diseases.
Market cap
$253m
Enterprise value
$109m
Share price
$7.62 SGMT
Authorizing premium user...
A biopharmaceutical company developing therapeutics for the treatment of infectious diseases.